BWS Financial Inc

BWS provides independent stock specific research focused on companies with distinct value that are going through a special situation where there is a tangible catalyst not priced in. The catalyst can be anything from new product, restructuring, M&A, management change, change in business strategy, etc. BWS’s focus is to understand the change and evaluate the potential return for investors.

BWS utilizes a self formed proprietary approach in discovering stocks by putting great emphasis on deep research. BWS does generate short recommendations following a similar criteria.

Independent Stock Specific Research

IPAR: Multiple Brands for Success in 2022, PT to $125

Founder, BWS Financial Inc

Hamed Khorsand

Founder

Equity Bottom-Up

<ul>
<li>IPAR has entered 2022 owning a series of new licenses and the reopening of international airports should result in sales growing at a faster pace than the current consensus estimates</li>
<li>In the case of the Donna Karan license, IPAR begins to recognize sales in the second half of the year when it is traditionally the peak sales period</li>
<li>The recent lifting of COVID-19 restrictions in Europe eases international travel, which should have a positive impact on sales in 2022</li>
</ul>


IPAR has entered 2022 owning a series of new licenses and the reopening of international airports should result in sales growing at a faster pace than the current consensus estimates
In the case of the Donna Karan license, IPAR begins to recognize sales in the second half of the year when it is traditionally the peak sales period
The recent lifting of COVID-19 restrictions in Europe eases international travel, which should have a positive impact on sales in 2022


Inter Parfums

IPAR: Growth Prospects of 2022